Literature DB >> 23447141

Mycobacterium canettii is intrinsically resistant to both pyrazinamide and pyrazinoic acid.

Silke Feuerriegel, Claudio U Köser, Elvira Richter, Stefan Niemann.   

Abstract

Entities:  

Keywords:  M. canettii; Mycobacterium tuberculosis complex; pyrazinamide resistance

Mesh：

Substances：

Year:  2013        PMID： 23447141     DOI： 10.1093/jac/dkt042

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  17 in total

1.  Mechanisms of Pyrazinamide Action and Resistance.

Authors:  Ying Zhang; Wanliang Shi; Wenhong Zhang; Denis Mitchison
Journal:  Microbiol Spectr       Date:  2013

2.  ESX-1-Independent Horizontal Gene Transfer by Mycobacterium tuberculosis Complex Strains.

Authors:  Jan Madacki; Mickael Orgeur; Guillem Mas Fiol; Wafa Frigui; Laurence Ma; Roland Brosch
Journal:  mBio       Date:  2021-05-18       Impact factor: 7.867

3.  Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis.

Authors:  Shuo Zhang; Jiazhen Chen; Wanliang Shi; Wei Liu; Wenhong Zhang; Ying Zhang
Journal:  Emerg Microbes Infect       Date:  2013-06-12       Impact factor: 7.163

4.  Revised Interpretation of the Hain Lifescience GenoType MTBC To Differentiate Mycobacterium canettii and Members of the Mycobacterium tuberculosis Complex.

Authors:  Chloé Loiseau; Daniela Brites; Irmgard Moser; Francesc Coll; Christine Pourcel; Suelee Robbe-Austerman; Vincent Escuyer; Kimberlee A Musser; Sharon J Peacock; Silke Feuerriegel; Thomas A Kohl; Stefan Niemann; Sebastien Gagneux; Claudio U Köser
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.938

5.  Culture-independent detection and characterisation of Mycobacterium tuberculosis and M. africanum in sputum samples using shotgun metagenomics on a benchtop sequencer.

Authors:  Emma L Doughty; Martin J Sergeant; Ifedayo Adetifa; Martin Antonio; Mark J Pallen
Journal:  PeerJ       Date:  2014-09-23       Impact factor: 2.984

6.  Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis.

Authors:  Wanliang Shi; Jiazhen Chen; Jie Feng; Peng Cui; Shuo Zhang; Xinhua Weng; Wenhong Zhang; Ying Zhang
Journal:  Emerg Microbes Infect       Date:  2014-08-13       Impact factor: 7.163

Review 7.  Smooth Tubercle Bacilli: Neglected Opportunistic Tropical Pathogens.

Authors:  Djaltou Aboubaker Osman; Feriel Bouzid; Stéphane Canaan; Michel Drancourt
Journal:  Front Public Health       Date:  2016-01-11

8.  Establishment and validation of whole-cell based fluorescence assays to identify anti-mycobacterial compounds using the Acanthamoeba castellanii-Mycobacterium marinum host-pathogen system.

Authors:  Sébastien Kicka; Valentin Trofimov; Christopher Harrison; Hajer Ouertatani-Sakouhi; John McKinney; Leonardo Scapozza; Hubert Hilbi; Pierre Cosson; Thierry Soldati
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

9.  Progenitor “Mycobacterium canettii” clone responsible for lymph node tuberculosis epidemic, Djibouti.

Authors:  Yann Blouin; Géraldine Cazajous; Céline Dehan; Charles Soler; Rithy Vong; Mohamed Osman Hassan; Yolande Hauck; Christian Boulais; Dina Andriamanantena; Christophe Martinaud; Émilie Martin; Christine Pourcel; Gilles Vergnaud
Journal:  Emerg Infect Dis       Date:  2014-01       Impact factor: 6.883

10.  Genetic diversity within Mycobacterium tuberculosis complex impacts on the accuracy of genotypic pyrazinamide drug-susceptibility assay.

Authors:  Claudio U Köser; Iñaki Comas; Silke Feuerriegel; Stefan Niemann; Sebastien Gagneux; Sharon J Peacock
Journal:  Tuberculosis (Edinb)       Date:  2014-04-24       Impact factor: 3.131
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.